*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Wall Street stocks turned sharply to close well below the waterline on Wednesday, as the US confirmed its first case of the ‘Omicron’ variant in California.
The market spotlight on Thursday will be on OPEC+ energy ministers as they meet to decide on whether to move ahead with a 400,000 barrel per day increase in their combined output come January or not.
Vaccinating people around the entire globe could cost a staggering $50bn, but it would be worth the effort, even if only because of the rather higher cost of not doing so, the rich world´s economic watchdog argued.
Analysts at Berenberg raised their target price on media firm Future from 4,890. 0p to 5,225. 0p on Wednesday following the publication of the group's solid full-year results.
Barclays upgraded Dr Martens to ‘overweight’ from ‘equalweight’ on Wednesday, keeping the price target at 480p, as it argued that the iconic footwear company has an "attractive brand with many levers to drive revenue and EBITDA growth".
JPMorgan initiated coverage of Tritax Big Box at ‘overweight’ on Wednesday with a 265p price target as it noted the company has a significant landbank of development opportunities.
Bourses around the region were mostly higher on Wednesday even after the head of the US central bank sounded a more hawkish note overnight and the head of US vaccine maker Moderna said current vaccines would struggle with Omicron, the new variant of Covid-19.
European markets continued their roller-coaster Omicron Covid-variant volatility ride on Wednesday morning as shares extended gains from the morning session.
Energy company SSE's wholly-owned subsidiary Scottish and Southern Electricity Networks Distribution published its final business plan for Ofgem's RIIO-ED2 price controls on Wednesday.
Bitcoin maintained its rebound on Monday and Tuesday, along with other risk assets, but failed to break above $60,000, yet again being pressured downwards. The November close has been above $57,000, which means a drop for the queen of the 'cryptos' of 7%. All in all, its annual boom remains at 100% and optimists still expect the crypto-asset to stage a rally to $70,000 before the end of the year. In recent hours, due to the words of Federal Reserve (Fed) Chairman, Jerome Powell, Bitcoin´s rises have been limited above $59,000.
House price growth continued at a brisk pace in November, buoyed by "robust" conditions in the labour market, but the multiple headwinds the sector was facing meant that the outlook was uncertain.
